THINK Surgical, Inc. obtains U.S. FDA 510(k) clearance to market the TSolution One® Total Knee Application for use in total knee arthroplasty (TKA).
THINK Surgical, Inc. completes U.S. FDA IDE clinical trial.
THINK Surgical, Inc. is awarded the CE marking for TKA.
The TSolution One Surgical System receives Korean FDA clearance for Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA).
The TSolution One Surgical System receives U.S. FDA clearance for Total Hip Arthroplasty (THA).
The 1989 ROBODOC® prototype, the TSolution One core technology, was added to the Smithsonian National Museum of American History as part of their Science and Medicine Collection.
THINK Surgical, Inc. receives FDA 510(k) clearance for Femoral Canal and Acetabular Cup Preparation.
THINK Surgical, Inc. becomes the new name of Curexo Technology Corporation.
The TSolution One® receives FDA 510(k) clearance and and CE marking for Femoral Canal Preparation during THA.
The first ROBODOC® Surgical System is established at Sutter General Hospital in Sacramento, CA
The ROBODOC Surgical System receives FDA 510(k) clearance for THA.
Total Knee Arthroplasty (TKA) Surgical System was introduced in Korea, Japan and India
The ROBODOC Surgical System is introduced to Europe for TKA.
The ROBODOC Surgical System is introduced to Europe for THA.
The ROBODOC team receives the Computerworld Smithsonian Award for Innovation in the Arts and Sciences.
The ROBODOC Surgical System assists a surgeon in a THA procedure−making medical history.
Researchers from IBM and the University of California, Davis, begin collaborative development of an innovative robotic surgical system for THA.
Sales and Product inquiriesProduct and Technical SupportInformation on CompanyOther